1-3 of 3
Oliver Gerhard Ottmann
Close
Sort by
Journal Articles

Inhibition of Phosphotyrosine Phosphatase-1B (PTP1B) Induces Resistance to the ABL Kinase Inhibitor Imatinib Mesylate (Gleevec®) in BCR-ABL Positive Leukemic Cells.

Noriko Koyama, PhD, Steffen Koschmieder, MD, Sandhya Tyagi, Silke Myloch, Heike Nuernberger, Tanja Rossmanith, PhD, Wolf Karsten Hofmann, PD MD, Dieter Hoelzer, PD MD, Oliver Gerhard Ottmann
Journal: Blood
Blood (2004) 104 (11): 2095.
https://doi.org/10.1182/blood.V104.11.2095.2095
Published: 2004
Journal Articles

γ-Catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells

Xiaomin Zheng, Tim Beissert, Natasa Kukoc-Zivojnov, Elena Puccetti, Joachim Altschmied, Corinna Strolz, Simone Boehrer, Hilal Gul, Orinta Schneider, Oliver Gerhard Ottmann, Dieter Hoelzer, Reinhard Henschler, Martin Ruthardt
Journal: Blood
Blood (2004) 103 (9): 3535–3543.
https://doi.org/10.1182/blood-2003-09-3335
Published: 2004
Journal Articles

Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571

Tim Beissert, Elena Puccetti, Andrea Bianchini, Saskia Güller, Simone Boehrer, Dieter Hoelzer, Oliver Gerhard Ottmann, Clara Nervi, Martin Ruthardt
Journal: Blood
Blood (2003) 102 (8): 2985–2993.
https://doi.org/10.1182/blood-2003-03-0811
Published: 2003